Cargando…
Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
BACKGROUND: Mass treatment to trachoma endemic communities is a critical part of the World Health Organization SAFE strategy. However, non-participation may not be at random, affecting coverage surveys and effectiveness if infection is differential. METHODOLOGY/PRINCIPAL FINDINGS: As part of the Par...
Autores principales: | Ssemanda, Elizabeth N., Munoz, Beatriz, Harding-Esch, Emma M., Edwards, Tansy, Mkocha, Harran, Bailey, Robin L., Sillah, Ansumana, Stare, Dianne, Mabey, David C. W., West, Sheila K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950137/ https://www.ncbi.nlm.nih.gov/pubmed/20957196 http://dx.doi.org/10.1371/journal.pntd.0000838 |
Ejemplares similares
-
Trachoma Prevalence and Associated Risk Factors in The Gambia and Tanzania: Baseline Results of a Cluster Randomised Controlled Trial
por: Harding-Esch, Emma M., et al.
Publicado: (2010) -
Azithromycin Mass Treatment for Trachoma Control: Risk Factors for Non-Participation of Children in Two Treatment Rounds
por: Ssemanda, Elizabeth N., et al.
Publicado: (2012) -
Non-Participation during Azithromycin Mass Treatment for Trachoma in The Gambia: Heterogeneity and Risk Factors
por: Edwards, Tansy, et al.
Publicado: (2014) -
A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
por: West, Sheila K., et al.
Publicado: (2013) -
Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control
por: Burr, Sarah E, et al.
Publicado: (2014)